Recce Pharmaceuticals Ltd.ASX: RCE

U.S. Government Releases US$66.9B AMR Biodefense Strategy

· Issued by Recce Pharmaceuticals Ltd. via ASX

Filed with ASX ·

ASX Announcement U.S. Government Releases US$66.9 Billion Antimicrobial Resistance Biodefense Strategy Highlights: • United States Government outlines a five-year, US$66.9 billion strategy to strengthen national defences against pandemics and drug-resistant superbugs ...

View Attachment

6ix hasn’t read this filing yet.

Recce Pharmaceuticals Ltd. on 6ix

Earlier from Recce Pharmaceuticals

Later from Recce Pharmaceuticals

All Recce Pharmaceuticals news releases